Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 8 March 2022
Revised: 18 March 2022
Accepted: 22 March 2022
First Online: 4 April 2022
Competing interests
: AM: consultancy to Veracyte, CA, USA (no financial compensation); VG: research grants from Novartis, Astellas, Astra Zeneca, Pfizer.
: Not applicable.
